AI & Emerging Technology

The tech-powered hair tool brand, a TikTok sensation, just launched on Ulta.com. Can its viral hype translate into mainstream success and brand longevity?

Robot orders surged 6.6% in 2025, driven by food, electronics, and life sciences, marking a major shift away from traditional automotive dominance.

With key FCC and CE certifications, Vuzix begins shipping its new AI-powered LX1 smart glasses, targeting a logistics market ripe for a tech upgrade.

Acarix's CADScor®System gains stringent EU MDR certification, a move poised to reshape cardiac diagnostics and fuel the company's expansion in the U.S.

Affinia Therapeutics gets the green light for a human trial of AFTX-201, a one-time therapy for a devastating genetic heart disease, BAG3 DCM.

With key data on its Duchenne muscular dystrophy drugs expected in 2026, Entrada's CEO Dipal Doshi will detail the firm's high-risk, high-reward strategy.

New 4-year real-world data shows Zevra's drug stabilizes the rare, fatal 'Childhood Alzheimer's' disease, marking a milestone for patients and families.

A new class of compounds 'disarms' TB bacteria instead of killing it, a breakthrough that could help defeat drug resistance and treat the world's deadliest disease.

US-vetted drones are heading north. EagleNXT's landmark sale to Canada signals a new era in security and a strategic shift away from Chinese tech.

Cyber threat intelligence firm Intel 471 elevates CINO Michael DeBolt to President, signaling a strategy to embed deep operational expertise into its core.

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

Keeper's new 2026 partner program offers tiered incentives and a cloud-native platform, aiming to make enterprise-grade privileged access management profitable for MSPs.

A new 'QuadAlliance' of industry leaders aims to mass-produce smart holographic windshields by 2029, promising to revolutionize the in-car experience.

Malaysia's largest telco, CelcomDigi, launches a unified distribution system for its 20M+ users, aiming to streamline sales and enhance partner collaboration.

Celanese completes a key divestiture to tackle its massive debt, while buyer Element Solutions bolsters its high-growth electronics portfolio.

Bolstered by a massive capital infusion and strong investor demand, Vaxcyte is set to accelerate its broad-spectrum vaccine pipeline against market leaders.

Bermuda insurer Relm adds C-suite leaders from AXIS and Zurich, signaling a strategic push to dominate insurance for AI, crypto, and space tech.

JScreen, Manischewitz, and advocate Gila Pfeffer offer low-cost cancer and carrier genetic tests in NYC, transforming community health access.

The University of Arizona's Eller College secures top spots in U.S. News rankings, validating its innovative, flexible online business programs.

Commvault's new solution addresses rising global demand for data control, helping organizations navigate complex regulations without sacrificing cyber resilience.